VAGIFEM

This brand name is authorized in United States. It is also authorized in Australia, Brazil, Canada, Croatia, Cyprus, Estonia, Finland, Hong Kong SAR China, Ireland, Israel, Lithuania, Malta, Netherlands, New Zealand, Poland, Singapore, South Africa, Spain, Turkey, UK.

Active ingredients

The drug VAGIFEM contains one active pharmaceutical ingredient (API):

1	Estradiol UNII CXY7B3Q98Z - ESTRADIOL HEMIHYDRATE
	Estradiol, is chemically and biologically identical to endogenous human estradiol. It substitutes for the loss of oestrogen production in menopausal women, and alleviates menopausal symptoms. Oestrogens prevent bone loss following menopause or ovariectomy.
	Read more about Estradiol

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
VAGIFEM Vaginal tablet	MPI, EU: SmPC	Health Products Regulatory Authority (IE)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
G03CA03	Estradiol	G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03C Estrogens → G03CA Natural and semisynthetic estrogens, plain
Discover more medicines within G03CA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	10203B
BR	Câmara de Regulação do Mercado de Medicamentos	542220090000807
CA	Health Products and Food Branch	02325462
EE	Ravimiamet	1035896, 1380721, 1380732
ES	Centro de información online de medicamentos de la AEMPS	72171
FI	Lääkealan turvallisuus- ja kehittämiskeskus	098460, 109499
GB	Medicines & Healthcare Products Regulatory Agency	180939
HK	Department of Health Drug Office	61339
HR	Agencija za lijekove i medicinske proizvode	HR-H-793020012
IE	Health Products Regulatory Authority	51303
IL	מִשְׂרַד הַבְּרִיאוּת	7196
LT	Valstybinė vaistų kontrolės tarnyba	1001934, 1034403, 1054621
MT	Medicines Authority	MA104/00302
NL	Z-Index G-Standaard, PRK	105023
NZ	Medicines and Medical Devices Safety Authority	14798
PL	Rejestru Produktów Leczniczych	100234019
SG	Health Sciences Authority	14877P
TR	İlaç ve Tıbbi Cihaz Kurumu	8699676100408, 8699676100415
US	FDA, National Drug Code	0169-5176
ZA	Health Products Regulatory Authority	27/21.8.1/0098, 47/21.8.1/0166